manufacturing approval / foreign healthcare reforms / with respect to product / /
MedicalCondition
nephrotic syndrome / /
Organization
Pharmaceutical Affairs and Food Sanitation Council / First Committee on New Drugs of the Pharmaceutical Affairs / Ministry of Health / Investigational Committee for the Unapproved Drugs and Off-label Drug Use / /
Shionogi Launches “Endoxan® Powder 100mg for Oral” for Nephrotic Syndrome Osaka, Japan, July 30, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) tod